United States Healthcare Equipment & Supplies

Tactile Systems Technology Inc (TCMD)

Track

Track

Tactile Systems Technology Inc. experienced net insider selling totaling approximately $323,243 over the past quarter. Following a positive earnings report, executives offloaded shares, contributing to a 15.3% decline in stock value. These transactions d'initiés reflect recent divestment activity by leadership amidst broader market volatility for this healthcare firm.
Ticker: TCMD Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Tactile Systems Technology Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.6
William W Burke board of director Non-Executive Director
Transaction date
Proposed sale
Price
36.87
Quantity 89,086
Value US$2,122,851
3.0
Dodd Sheri Louise Chief Executive Officer Executive Director
Transaction date
Sale
Price
431.66
Quantity 51,342 +39.0%
Value US$2,342,058
3.0
Dodd Sheri Louise Officer; Director Executive Director
Transaction date
Proposed sale
Price
15.25
Quantity 78,902
Value US$2,597,312
3.2
Birkemeyer Elaine M. CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
24.49
Quantity 4,631 -3.4%
Value US$113,404
3.2
Birkemeyer Elaine M. Officer Officer
Transaction date
Proposed sale
Price
24.49
Quantity 4,631
Value US$113,404
3.7
Burns Kristie Officer Officer
Transaction date
Proposed sale
Price
28.47
Quantity 4,000
Value US$113,880
3.0
Dodd Sheri Louise Chief Executive Officer Executive Director
Transaction date
Sale
Price
28.94
Quantity 10,993 -4.3%
Value US$318,144
3.7
Burns Kristie Sr. VP Mktg & Clinical Affairs Officer
Transaction date
Sale
Price
28.94
Quantity 6,246 -7.0%
Value US$180,764
3.2
Birkemeyer Elaine M. CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
28.94
Quantity 7,701 -5.4%
Value US$222,880
3.0
Dodd Sheri Louise Officer; Director Executive Director
Transaction date
Proposed sale
Price
28.94
Quantity 10,993
Value US$318,148
3.2
Birkemeyer Elaine M. Officer Officer
Transaction date
Proposed sale
Price
28.94
Quantity 7,701
Value US$222,875
3.7
Burns Kristie Officer Officer
Transaction date
Proposed sale
Price
28.94
Quantity 6,246
Value US$180,765
3.2
Birkemeyer Elaine M. CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
28.69
Quantity 196 -0.1%
Value US$5,623
3.2
Birkemeyer Elaine M. CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
28.28
Quantity 5,322 -3.6%
Value US$150,521
3.0
Dodd Sheri Louise Chief Executive Officer Executive Director
Transaction date
Sale
Price
28.69
Quantity 537 -0.2%
Value US$15,406
3.0
Dodd Sheri Louise Chief Executive Officer Executive Director
Transaction date
Sale
Price
28.28
Quantity 14,703 -5.4%
Value US$415,839
3.7
Burns Kristie Sr. VP Mktg & Clinical Affairs Officer
Transaction date
Sale
Price
28.69
Quantity 160 -0.2%
Value US$4,590
3.7
Burns Kristie Sr. VP Mktg & Clinical Affairs Officer
Transaction date
Sale
Price
28.28
Quantity 4,279 -4.6%
Value US$121,022
3.7
Burns Kristie Officer Officer
Transaction date
Proposed sale
Price
28.30
Quantity 4,439
Value US$125,610
3.0
Dodd Sheri Louise Officer; Director Executive Director
Transaction date
Proposed sale
Price
28.30
Quantity 15,240
Value US$431,246
3.2
Birkemeyer Elaine M. Officer Officer
Transaction date
Proposed sale
Price
28.30
Quantity 5,518
Value US$156,143
3.7
Burns Kristie Sr. VP Mktg & Clinical Affairs Officer
Transaction date
Planned sale
Price
28.85
Quantity 5,139 -6.6%
Value US$148,260
3.7
Burns Kristie Officer Officer
Transaction date
Proposed sale
Price
28.85
Quantity 5,139
Value US$148,260
3.0
Dodd Sheri Louise Chief Executive Officer Executive Director
Transaction date
Sale
Price
12.36
Quantity 7,762 -4.3%
Value US$95,907
3.0
Dodd Sheri Louise Officer; Director Executive Director
Transaction date
Proposed sale
Price
12.36
Quantity 7,762
Value US$95,906
3.2
Birkemeyer Elaine M. Chief Financial Officer Officer
Transaction date
Planned sale
Price
9.94
Quantity 2,921 -2.9%
Value US$29,037
3.2
Birkemeyer Elaine M. Officer Officer
Transaction date
Proposed sale
Price
9.94
Quantity 2,921
Value US$29,037
3.0
Dodd Sheri Louise Chief Executive Officer Executive Director
Transaction date
Sale
Price
9.83
Quantity 3,149 -1.7%
Value US$30,955
2.6
BURKE WILLIAM W Non-Executive Director
Transaction date
Planned sale
Price
9.67
Quantity 3,300 -6.4%
Value US$31,911
3.0
Dodd Sheri Louise Director Non-Executive Director
Transaction date
Proposed sale
Price
9.83
Quantity 3,149
Value US$30,955
2.6
BURKE WILLIAM W Director Non-Executive Director
Transaction date
Proposed sale
Price
9.67
Quantity 3,300
Value US$31,911
0.8
Ferstler Sherri Lee Officer Officer
Transaction date
Proposed sale
Price
13.14
Quantity 2,355
Value US$30,945
3.6
REUVERS DANIEL L. Non-Executive Director
Transaction date
Planned sale
Price
14.18
Quantity 28,338 -11.7%
Value US$401,850
3.7
Burns Kristie Sr. VP Mktg & Clinical Affairs Officer
Transaction date
Sale
Price
14.40
Quantity 6,468 -7.7%
Value US$93,160
3.2
Birkemeyer Elaine M. Chief Financial Officer Officer
Transaction date
Planned sale
Price
14.51
Quantity 2,066 -2.0%
Value US$29,980
3.6
REUVERS DANIEL L. Officer Officer
Transaction date
Proposed sale
Price
14.18
Quantity 28,338
Value US$401,851
3.7
Burns Kristie Officer Officer
Transaction date
Proposed sale
Price
14.40
Quantity 6,468
Value US$93,160
3.2
Birkemeyer Elaine M. Officer Officer
Transaction date
Proposed sale
Price
14.51
Quantity 2,066
Value US$29,980
3.6
REUVERS DANIEL L. Officer Officer
Transaction date
Proposed sale
Price
14.55
Quantity 10,938
Value US$159,147
3.7
Burns Kristie Officer Officer
Transaction date
Proposed sale
Price
14.65
Quantity 4,830
Value US$70,753
0.8
Ferstler Sherri Lee Officer Officer
Transaction date
Proposed sale
Price
14.79
Quantity 2,209
Value US$32,660
3.2
Birkemeyer Elaine M. Officer Officer
Transaction date
Proposed sale
Price
14.70
Quantity 3,778
Value US$55,538
3.6
REUVERS DANIEL L. Non-Executive Director
Transaction date
Planned sale
Price
14.55
Quantity 10,938 -4.3%
Value US$159,147
3.2
Birkemeyer Elaine M. Chief Financial Officer Officer
Transaction date
Planned sale
Price
14.70
Quantity 3,778 -3.5%
Value US$55,538
3.7
Burns Kristie Sr. VP Mktg & Clinical Affairs Officer
Transaction date
Sale
Price
14.65
Quantity 4,830 -5.4%
Value US$70,753
0.8
Ferstler Sherri Lee Senior VP, Sales Officer
Transaction date
Sale
Price
13.07
Quantity 1,550 -3.8%
Value US$20,263
0.8
Ferstler Sherri Lee Officer Officer
Transaction date
Proposed sale
Price
13.07
Quantity 1,550
Value US$20,262
3.2
Birkemeyer Elaine M. Chief Financial Officer Officer
Transaction date
Sale
Price
13.68
Quantity 3,041 -4.7%
Value US$41,590
3.2
Birkemeyer Elaine M. Officer Officer
Transaction date
Proposed sale
Price
13.68
Quantity 3,041
Value US$41,590
2.6
BURKE WILLIAM W Non-Executive Director
Transaction date
Planned sale
Price
14.06
Quantity 2,500 -9.0%
Value US$35,150
2.6
BURKE WILLIAM W Director Non-Executive Director
Transaction date
Proposed sale
Price
14.06
Quantity 2,500
Value US$35,150
3.7
Burns Kristie Sr. VP Mktg & Clinical Affairs Officer
Transaction date
Sale
Price
14.37
Quantity 815 -1.3%
Value US$11,713
3.7
Burns Kristie Officer Officer
Transaction date
Proposed sale
Price
14.37
Quantity 815
Value US$11,713
3.6
REUVERS DANIEL L. Officer Officer
Transaction date
Proposed sale
Price
15.25
Quantity 1,396
Value US$21,289
3.7
Burns Kristie Officer Officer
Transaction date
Proposed sale
Price
15.25
Quantity 243
Value US$3,706
3.6
REUVERS DANIEL L. President and CEO Executive Director
Transaction date
Planned sale
Price
15.25
Quantity 1,396 -0.6%
Value US$21,289
3.7
Burns Kristie Sr. VP Mktg & Clinical Affairs Officer
Transaction date
Planned sale
Price
15.25
Quantity 243 -0.4%
Value US$3,706
3.6
REUVERS DANIEL L. President and CEO Executive Director
Transaction date
Planned sale
Price
15.60
Quantity 4,689 -1.9%
Value US$73,148
3.7
Burns Kristie Sr. VP Mktg & Clinical Affairs Officer
Transaction date
Planned sale
Price
15.58
Quantity 1,091 -1.7%
Value US$17,001
3.6
REUVERS DANIEL L. Officer Officer
Transaction date
Proposed sale
Price
15.60
Quantity 4,689
Value US$73,148
3.7
Burns Kristie Officer Officer
Transaction date
Proposed sale
Price
15.58
Quantity 1,091
Value US$17,001
3.7
Burns Kristie Sr. VP Mktg & Clinical Affairs Officer
Transaction date
Planned sale
Price
15.91
Quantity 2,015 -3.1%
Value US$32,049
3.6
REUVERS DANIEL L. President and CEO Executive Director
Transaction date
Planned sale
Price
15.81
Quantity 6,239 -2.5%
Value US$98,645
3.6
REUVERS DANIEL L. Officer Officer
Transaction date
Proposed sale
Price
15.81
Quantity 6,239
Value US$98,645
3.7
Burns Kristie Officer Officer
Transaction date
Proposed sale
Price
15.91
Quantity 2,015
Value US$32,049
3.7
Burns Kristie Sr. VP Mktg & Clinical Affairs Officer
Transaction date
Planned sale
Price
14.80
Quantity 2,249 -4.0%
Value US$33,278
3.6
REUVERS DANIEL L. President and CEO Executive Director
Transaction date
Planned sale
Price
14.85
Quantity 5,378 -2.7%
Value US$79,853
3.7
Burns Kristie Officer Officer
Transaction date
Proposed sale
Price
14.80
Quantity 2,249
Value US$33,278
3.6
REUVERS DANIEL L. Officer Officer
Transaction date
Proposed sale
Price
14.85
Quantity 5,378
Value US$79,853
3.6
REUVERS DANIEL L. President and CEO Executive Director
Transaction date
Sale
Price
20.53
Quantity 1,062 -0.8%
Value US$21,808
3.6
REUVERS DANIEL L. Officer; Director Executive Director
Transaction date
Proposed sale
Price
20.53
Quantity 1,062
Value US$21,808
2.6
BURKE WILLIAM W Non-Executive Director
Transaction date
Planned sale
Price
21.86
Quantity 4,400 -13.7%
Value US$96,184
2.6
BURKE WILLIAM W Director Non-Executive Director
Transaction date
Proposed sale
Price
21.86
Quantity 4,400
Value US$96,184
3.7
Burns Kristie Sr. VP Mktg & Clinical Affairs Officer
Transaction date
Planned sale
Price
18.65
Quantity 786 -2.1%
Value US$14,659
2.0
PAULS ERIC Senior VP, Sales Officer
Transaction date
Planned sale
Price
18.55
Quantity 550 -1.8%
Value US$10,200
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-20 2026-08-19 PrS Proposed sale
2.6
William W Burke

board of director

Non-Executive Director
89,086
36.87
US$2,122,851 		89,086 36.87 US$2,122,851
2026-08-12 2026-08-10 S Sale
3.0
Dodd Sheri Louise

Chief Executive Officer

Executive Director
51,342 +39.0%
431.66
US$2,342,058 		51,342 +39.0% 431.66 US$2,342,058
2026-08-10 2026-08-10 PrS Proposed sale
3.0
Dodd Sheri Louise

Officer; Director

Executive Director
78,902
15.25
US$2,597,312 		78,902 15.25 US$2,597,312
2026-05-13 2026-05-11 S Sale
3.2
Birkemeyer Elaine M.

CHIEF FINANCIAL OFFICER

Officer
4,631 -3.4%
24.49
US$113,404 		4,631 -3.4% 24.49 US$113,404
2026-05-11 2026-05-11 PrS Proposed sale
3.2
Birkemeyer Elaine M.

Officer

Officer
4,631
24.49
US$113,404 		4,631 24.49 US$113,404
2026-02-25 2026-02-25 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
4,000
28.47
US$113,880 		4,000 28.47 US$113,880
2026-02-26 2026-02-24 S Sale
3.0
Dodd Sheri Louise

Chief Executive Officer

Executive Director
10,993 -4.3%
28.94
US$318,144 		10,993 -4.3% 28.94 US$318,144
2026-02-26 2026-02-24 S Sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
6,246 -7.0%
28.94
US$180,764 		6,246 -7.0% 28.94 US$180,764
2026-02-26 2026-02-24 S Sale
3.2
Birkemeyer Elaine M.

CHIEF FINANCIAL OFFICER

Officer
7,701 -5.4%
28.94
US$222,880 		7,701 -5.4% 28.94 US$222,880
2026-02-24 2026-02-24 PrS Proposed sale
3.0
Dodd Sheri Louise

Officer; Director

Executive Director
10,993
28.94
US$318,148 		10,993 28.94 US$318,148
2026-02-24 2026-02-24 PrS Proposed sale
3.2
Birkemeyer Elaine M.

Officer

Officer
7,701
28.94
US$222,875 		7,701 28.94 US$222,875
2026-02-24 2026-02-24 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
6,246
28.94
US$180,765 		6,246 28.94 US$180,765
2026-02-24 2026-02-23 S Sale
3.2
Birkemeyer Elaine M.

CHIEF FINANCIAL OFFICER

Officer
196 -0.1%
28.69
US$5,623 		196 -0.1% 28.69 US$5,623
2026-02-24 2026-02-23 S Sale
3.2
Birkemeyer Elaine M.

CHIEF FINANCIAL OFFICER

Officer
5,322 -3.6%
28.28
US$150,521 		5,322 -3.6% 28.28 US$150,521
2026-02-24 2026-02-23 S Sale
3.0
Dodd Sheri Louise

Chief Executive Officer

Executive Director
537 -0.2%
28.69
US$15,406 		537 -0.2% 28.69 US$15,406
2026-02-24 2026-02-23 S Sale
3.0
Dodd Sheri Louise

Chief Executive Officer

Executive Director
14,703 -5.4%
28.28
US$415,839 		14,703 -5.4% 28.28 US$415,839
2026-02-24 2026-02-23 S Sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
160 -0.2%
28.69
US$4,590 		160 -0.2% 28.69 US$4,590
2026-02-24 2026-02-23 S Sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
4,279 -4.6%
28.28
US$121,022 		4,279 -4.6% 28.28 US$121,022
2026-02-23 2026-02-23 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
4,439
28.30
US$125,610 		4,439 28.30 US$125,610
2026-02-23 2026-02-23 PrS Proposed sale
3.0
Dodd Sheri Louise

Officer; Director

Executive Director
15,240
28.30
US$431,246 		15,240 28.30 US$431,246
2026-02-23 2026-02-23 PrS Proposed sale
3.2
Birkemeyer Elaine M.

Officer

Officer
5,518
28.30
US$156,143 		5,518 28.30 US$156,143
2026-01-06 2026-01-02 PlS Planned sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
5,139 -6.6%
28.85
US$148,260 		5,139 -6.6% 28.85 US$148,260
2026-01-02 2026-01-02 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
5,139
28.85
US$148,260 		5,139 28.85 US$148,260
2025-08-12 2025-08-08 S Sale
3.0
Dodd Sheri Louise

Chief Executive Officer

Executive Director
7,762 -4.3%
12.36
US$95,907 		7,762 -4.3% 12.36 US$95,907
2025-08-08 2025-08-08 PrS Proposed sale
3.0
Dodd Sheri Louise

Officer; Director

Executive Director
7,762
12.36
US$95,906 		7,762 12.36 US$95,906
2025-05-14 2025-05-12 PlS Planned sale
3.2
Birkemeyer Elaine M.

Chief Financial Officer

Officer
2,921 -2.9%
9.94
US$29,037 		2,921 -2.9% 9.94 US$29,037
2025-05-12 2025-05-12 PrS Proposed sale
3.2
Birkemeyer Elaine M.

Officer

Officer
2,921
9.94
US$29,037 		2,921 9.94 US$29,037
2025-05-12 2025-05-08 S Sale
3.0
Dodd Sheri Louise

Chief Executive Officer

Executive Director
3,149 -1.7%
9.83
US$30,955 		3,149 -1.7% 9.83 US$30,955
2025-05-09 2025-05-08 PlS Planned sale
2.6
BURKE WILLIAM W
Non-Executive Director
3,300 -6.4%
9.67
US$31,911 		3,300 -6.4% 9.67 US$31,911
2025-05-08 2025-05-08 PrS Proposed sale
3.0
Dodd Sheri Louise

Director

Non-Executive Director
3,149
9.83
US$30,955 		3,149 9.83 US$30,955
2025-05-08 2025-05-08 PrS Proposed sale
2.6
BURKE WILLIAM W

Director

Non-Executive Director
3,300
9.67
US$31,911 		3,300 9.67 US$31,911
2025-04-03 2025-04-03 PrS Proposed sale
0.8
Ferstler Sherri Lee

Officer

Officer
2,355
13.14
US$30,945 		2,355 13.14 US$30,945
2025-02-27 2025-02-25 PlS Planned sale
3.6
REUVERS DANIEL L.
Non-Executive Director
28,338 -11.7%
14.18
US$401,850 		28,338 -11.7% 14.18 US$401,850
2025-02-27 2025-02-25 S Sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
6,468 -7.7%
14.40
US$93,160 		6,468 -7.7% 14.40 US$93,160
2025-02-27 2025-02-25 PlS Planned sale
3.2
Birkemeyer Elaine M.

Chief Financial Officer

Officer
2,066 -2.0%
14.51
US$29,980 		2,066 -2.0% 14.51 US$29,980
2025-02-25 2025-02-25 PrS Proposed sale
3.6
REUVERS DANIEL L.

Officer

Officer
28,338
14.18
US$401,851 		28,338 14.18 US$401,851
2025-02-25 2025-02-25 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
6,468
14.40
US$93,160 		6,468 14.40 US$93,160
2025-02-25 2025-02-25 PrS Proposed sale
3.2
Birkemeyer Elaine M.

Officer

Officer
2,066
14.51
US$29,980 		2,066 14.51 US$29,980
2025-02-24 2025-02-24 PrS Proposed sale
3.6
REUVERS DANIEL L.

Officer

Officer
10,938
14.55
US$159,147 		10,938 14.55 US$159,147
2025-02-24 2025-02-24 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
4,830
14.65
US$70,753 		4,830 14.65 US$70,753
2025-02-24 2025-02-24 PrS Proposed sale
0.8
Ferstler Sherri Lee

Officer

Officer
2,209
14.79
US$32,660 		2,209 14.79 US$32,660
2025-02-24 2025-02-24 PrS Proposed sale
3.2
Birkemeyer Elaine M.

Officer

Officer
3,778
14.70
US$55,538 		3,778 14.70 US$55,538
2025-02-24 2025-02-24 PlS Planned sale
3.6
REUVERS DANIEL L.
Non-Executive Director
10,938 -4.3%
14.55
US$159,147 		10,938 -4.3% 14.55 US$159,147
2025-02-24 2025-02-24 PlS Planned sale
3.2
Birkemeyer Elaine M.

Chief Financial Officer

Officer
3,778 -3.5%
14.70
US$55,538 		3,778 -3.5% 14.70 US$55,538
2025-02-24 2025-02-24 S Sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
4,830 -5.4%
14.65
US$70,753 		4,830 -5.4% 14.65 US$70,753
2024-08-14 2024-08-12 S Sale
0.8
Ferstler Sherri Lee

Senior VP, Sales

Officer
1,550 -3.8%
13.07
US$20,263 		1,550 -3.8% 13.07 US$20,263
2024-08-12 2024-08-12 PrS Proposed sale
0.8
Ferstler Sherri Lee

Officer

Officer
1,550
13.07
US$20,262 		1,550 13.07 US$20,262
2024-05-20 2024-05-16 S Sale
3.2
Birkemeyer Elaine M.

Chief Financial Officer

Officer
3,041 -4.7%
13.68
US$41,590 		3,041 -4.7% 13.68 US$41,590
2024-05-16 2024-05-16 PrS Proposed sale
3.2
Birkemeyer Elaine M.

Officer

Officer
3,041
13.68
US$41,590 		3,041 13.68 US$41,590
2024-05-10 2024-05-08 PlS Planned sale
2.6
BURKE WILLIAM W
Non-Executive Director
2,500 -9.0%
14.06
US$35,150 		2,500 -9.0% 14.06 US$35,150
2024-05-08 2024-05-08 PrS Proposed sale
2.6
BURKE WILLIAM W

Director

Non-Executive Director
2,500
14.06
US$35,150 		2,500 14.06 US$35,150
2024-05-08 2024-05-06 S Sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
815 -1.3%
14.37
US$11,713 		815 -1.3% 14.37 US$11,713
2024-05-06 2024-05-06 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
815
14.37
US$11,713 		815 14.37 US$11,713
2024-02-29 2024-02-29 PrS Proposed sale
3.6
REUVERS DANIEL L.

Officer

Officer
1,396
15.25
US$21,289 		1,396 15.25 US$21,289
2024-02-29 2024-02-29 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
243
15.25
US$3,706 		243 15.25 US$3,706
2024-02-29 2024-02-29 PlS Planned sale
3.6
REUVERS DANIEL L.

President and CEO

Executive Director
1,396 -0.6%
15.25
US$21,289 		1,396 -0.6% 15.25 US$21,289
2024-02-29 2024-02-29 PlS Planned sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
243 -0.4%
15.25
US$3,706 		243 -0.4% 15.25 US$3,706
2024-02-29 2024-02-27 PlS Planned sale
3.6
REUVERS DANIEL L.

President and CEO

Executive Director
4,689 -1.9%
15.60
US$73,148 		4,689 -1.9% 15.60 US$73,148
2024-02-29 2024-02-27 PlS Planned sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
1,091 -1.7%
15.58
US$17,001 		1,091 -1.7% 15.58 US$17,001
2024-02-27 2024-02-27 PrS Proposed sale
3.6
REUVERS DANIEL L.

Officer

Officer
4,689
15.60
US$73,148 		4,689 15.60 US$73,148
2024-02-27 2024-02-27 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
1,091
15.58
US$17,001 		1,091 15.58 US$17,001
2024-02-27 2024-02-26 PlS Planned sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
2,015 -3.1%
15.91
US$32,049 		2,015 -3.1% 15.91 US$32,049
2024-02-27 2024-02-26 PlS Planned sale
3.6
REUVERS DANIEL L.

President and CEO

Executive Director
6,239 -2.5%
15.81
US$98,645 		6,239 -2.5% 15.81 US$98,645
2024-02-26 2024-02-26 PrS Proposed sale
3.6
REUVERS DANIEL L.

Officer

Officer
6,239
15.81
US$98,645 		6,239 15.81 US$98,645
2024-02-26 2024-02-26 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
2,015
15.91
US$32,049 		2,015 15.91 US$32,049
2024-02-27 2024-02-23 PlS Planned sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
2,249 -4.0%
14.80
US$33,278 		2,249 -4.0% 14.80 US$33,278
2024-02-27 2024-02-23 PlS Planned sale
3.6
REUVERS DANIEL L.

President and CEO

Executive Director
5,378 -2.7%
14.85
US$79,853 		5,378 -2.7% 14.85 US$79,853
2024-02-23 2024-02-23 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
2,249
14.80
US$33,278 		2,249 14.80 US$33,278
2024-02-23 2024-02-23 PrS Proposed sale
3.6
REUVERS DANIEL L.

Officer

Officer
5,378
14.85
US$79,853 		5,378 14.85 US$79,853
2023-08-09 2023-08-07 S Sale
3.6
REUVERS DANIEL L.

President and CEO

Executive Director
1,062 -0.8%
20.53
US$21,808 		1,062 -0.8% 20.53 US$21,808
2023-08-07 2023-08-07 PrS Proposed sale
3.6
REUVERS DANIEL L.

Officer; Director

Executive Director
1,062
20.53
US$21,808 		1,062 20.53 US$21,808
2023-05-16 2023-05-12 PlS Planned sale
2.6
BURKE WILLIAM W
Non-Executive Director
4,400 -13.7%
21.86
US$96,184 		4,400 -13.7% 21.86 US$96,184
2023-05-12 2023-05-12 PrS Proposed sale
2.6
BURKE WILLIAM W

Director

Non-Executive Director
4,400
21.86
US$96,184 		4,400 21.86 US$96,184
2023-05-10 2023-05-08 PlS Planned sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
786 -2.1%
18.65
US$14,659 		786 -2.1% 18.65 US$14,659
2023-05-10 2023-05-08 PlS Planned sale
2.0
PAULS ERIC

Senior VP, Sales

Officer
550 -1.8%
18.55
US$10,200 		550 -1.8% 18.55 US$10,200
Explore more

More insider trading research around Tactile Systems Technology Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America